Lasa Supergenerics Limited (LASA) - Total Liabilities

Latest as of September 2025: Rs152.61 Million INR ≈ $1.65 Million USD

Based on the latest financial reports, Lasa Supergenerics Limited (LASA) has total liabilities worth Rs152.61 Million INR (≈ $1.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Lasa Supergenerics Limited to assess how effectively this company generates cash.

Lasa Supergenerics Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Lasa Supergenerics Limited's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Lasa Supergenerics Limited to evaluate the company's liquid asset resilience ratio.

Lasa Supergenerics Limited Competitors by Total Liabilities

The table below lists competitors of Lasa Supergenerics Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Groupe JAJ PA:GJAJ	France	€26.76 Million
Zenvia Inc NASDAQ:ZENV	USA	$930.11 Million
Binani Industries Limited NSE:BINANIIND	India	Rs2.02 Billion
Celtic plc LSE:CCPC	UK	GBX89.90 Million
The Dixie Group Inc NASDAQ:DXYN	USA	$172.16 Million
MOVIE GAMES S.A. ZY1 F:2LH	Germany	€5.65 Million
NCL International Logistics Public Company Limited BK:NCL	Thailand	฿562.45 Million
Gungnir Resources Inc V:GUG	Canada	CA$3.02K

Liability Composition Analysis (2017–2025)

This chart breaks down Lasa Supergenerics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Lasa Supergenerics Limited.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.03	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lasa Supergenerics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lasa Supergenerics Limited (2017–2025)

The table below shows the annual total liabilities of Lasa Supergenerics Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs178.19 Million ≈ $1.93 Million	-67.12%
2024-03-31	Rs541.92 Million ≈ $5.86 Million	+18.92%
2023-03-31	Rs455.69 Million ≈ $4.93 Million	-11.15%
2022-03-31	Rs512.87 Million ≈ $5.55 Million	+4.79%
2021-03-31	Rs489.43 Million ≈ $5.29 Million	-45.93%
2020-03-31	Rs905.23 Million ≈ $9.79 Million	-40.91%
2019-03-31	Rs1.53 Billion ≈ $16.57 Million	-9.59%
2018-03-31	Rs1.69 Billion ≈ $18.32 Million	+10.92%
2017-03-31	Rs1.53 Billion ≈ $16.52 Million	--

About Lasa Supergenerics Limited

NSE:LASA India Drug Manufacturers - Specialty & Generic

Market Cap

$4.33 Million

Rs400.81 Million INR

Market Cap Rank

#28631 Global

#1612 in India

Share Price

Rs8.00

Change (1 day)

-1.23%

52-Week Range

Rs5.67 - Rs18.47

All Time High

Rs206.80